Judith L' Reishtein, Greg Maislin, David F' Dinges, Allan I' Pack, Terri E' Weaver, and the Multisit - PowerPoint PPT Presentation

1 / 1
About This Presentation
Title:

Judith L' Reishtein, Greg Maislin, David F' Dinges, Allan I' Pack, Terri E' Weaver, and the Multisit

Description:

Multisite Group: M. Mahowald, Hennepin County Medical Center, Minneapolis MN. ... Louis, MO, T. Bloxham, Wichita Clinic, Wichita, KS, C.F.P. George, Univ. Western ... – PowerPoint PPT presentation

Number of Views:46
Avg rating:3.0/5.0
Slides: 2
Provided by: reis61
Category:

less

Transcript and Presenter's Notes

Title: Judith L' Reishtein, Greg Maislin, David F' Dinges, Allan I' Pack, Terri E' Weaver, and the Multisit


1
Prediction of Improvement in Sleepiness and
Function Following CPAP Treatment
Judith L. Reishtein, Greg Maislin, David F.
Dinges, Allan I. Pack, Terri E. Weaver, and the
Multisite Group University of Pennsylvania Multisi
te Group M. Mahowald, Hennepin County Medical
Center, Minneapolis MN., G. Kader , St. Lukes
Hospital, St. Louis, MO, T. Bloxham, Wichita
Clinic, Wichita, KS, C.F.P. George, Univ. Western
Ontario, Ontario, CA, H. Greenberg, Long Island
Jewish Medical Center, NY, J. Younger, Holy
Family Bon Secours Regional Health System,
Altoona ,PA
Methods
Predictor equations
Table 1 Sample Description
In the following predictor equations, variablept
is an individual patients value
  • Subjects were recruited from 7 sleep clinics in
    US and Canada following diagnostic PSG if they
    were 21-60 years old, had an apnea-hypopnea index
    (AHI) gt 15 and excessive daytime sleepiness
  • Following informed consent, they completed
    baseline testing Multiple Sleep Latency Test
    (MSLT), Epworth Sleepiness Scale (ESS),
    Functional Outcomes of Sleep Questionnaire
    (FOSQ), and neurobehavioral tests (not reported
    here)

1) MSLT 4.45 0.05 (AHIpt 63.9) - .44
(baseline MSLTpt 6.8) 0.10 (agept
46.7) site specific value r2 0.34, p lt
.0001 2) ESS -5.92 - 0.67 (baseline ESSpt
15.0) site specific value r2 0.44, p lt
.0001 3) FOSQ total 2.23 .02 (AHIpt
63.9) - 0.65 (baseline FOSQpt 14.7 ) site
specific value r2 0.55, p lt .0001
  • Following testing session, subjects were
    instructed in use of CPAP and given machine to
    use at home
  • CPAP use was monitored
  • After 3 months CPAP treatment, subjects returned
    to sleep clinic for repeat of all baseline tests
  • Data were analyzed using SAS.
  • Variables were examined as predictors of change
    in each study outcome baseline value of outcome,
    age, BMI, AHI, site, and CPAP use. After
    calculating the means of each candidate predictor
    variable, we used these values to center each
    variable prior to inclusion in the regression
    models. As a consequence, the regression model
    intercepts could be interpreted as the predicted
    change for a person of average age, BMI, and RDI.

Conclusions
Table 2 Changes in outcomesfrom baseline to
post treatment
  • CPAP use for 3 months significantly improves
    subjectively and objectively measured daytime
    sleepiness and functional status
  • We demonstrate a method of predicting improvement
    with treatment from baseline condition, the
    strongest predictor for each outcome being the
    baseline value of that outcome. The site of
    testing adds to the predictive ability of the
    equations for all three outcomes, and the AHI
    adds to the predictive ability of the equations
    for the MSLT and FOSQ.
  • These predictions could be used in pretreatment
    counseling to increase adherence to CPAP.
    treatment, and enhance post treatment outcome.
  • Further research is needed to develop a profile
    of those who would optimally respond to
    treatment.

p lt 0.001
Funded by NHLBI, Respironics, Inc, DeVilbiss
Health Care, Nellcor Puritan Bennett,
Healthdyne Technologies, Inc
Write a Comment
User Comments (0)
About PowerShow.com